Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota
about
Effect of Mineralocorticoid Receptor Antagonists on Cardiac Structure and Function in Patients With Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: A Meta-Analysis and Systematic ReviewHeart failure with preserved ejection fraction: mechanisms, clinical features, and therapiesHeart failure with preserved ejection fractionAging-associated cardiovascular changes and their relationship to heart failureThe cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fractionClinical Phenotypes in Heart Failure With Preserved Ejection FractionRepression of miR-142 by p300 and MAPK is required for survival signalling via gp130 during adaptive hypertrophyImproved arterial-ventricular coupling in metabolic syndrome after exercise training: a pilot study.Treating anemia in older adults with heart failure with a preserved ejection fraction with epoetin alfa: single-blind randomized clinical trial of safety and efficacy.Diastolic stiffness as assessed by diastolic wall strain is associated with adverse remodelling and poor outcomes in heart failure with preserved ejection fractionComparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction.Risk factors for heart failure are associated with alterations of the LV end-diastolic pressure-volume relationship in non-heart failure individuals: data from a large-scale, population-based cohort.Advances in the pathophysiology and treatment of heart failure with preserved ejection fractionComparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitusDeveloping therapies for heart failure with preserved ejection fraction: current state and future directionsUpdate on heart failure with preserved ejection fraction.The restoration of chronotropic competence in heart failure patients with normal ejection fraction (RESET) study: rationale and design.Size, shape, and stamina: the impact of left ventricular geometry on exercise capacity.Physiologic basis and pathophysiologic implications of the diastolic properties of the cardiac muscleGlobal cardiovascular reserve dysfunction in heart failure with preserved ejection fractionProgression of preclinical diastolic dysfunction to the development of symptoms.Epidemiology and clinical course of heart failure with preserved ejection fractionDiuretics as pathogenetic treatment for heart failure.Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction.Decreased cardiac functional reserve in heart failure with preserved systolic function.Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.Elevated augmentation index derived from peripheral arterial tonometry is associated with abnormal ventricular-vascular couplingContribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fractionEffects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fraction.Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community.Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial.Pressure overload-dependent membrane type 1-matrix metalloproteinase induction: relationship to LV remodeling and fibrosis.Arterial-ventricular coupling with aging and diseaseIndependent associations of glucose status and arterial stiffness with left ventricular diastolic dysfunction: an 8-year follow-up of the Hoorn Study.Is obesity predictive of cardiovascular dysfunction independent of cardiovascular risk factors?Heart failure with a normal ejection fraction: treatments for a complex syndrome?Arterial stiffness and wave reflection: sex differences and relationship with left ventricular diastolic function.Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum.HDACs Regulate miR-133a Expression in Pressure Overload-Induced Cardiac Fibrosis.Myosin cross-bridge dynamics in patients with hypertension and concentric left ventricular remodeling.
P2860
Q26783958-2CFA2FFC-CCEE-4D7B-8F81-B2C4572355F5Q27000263-8B616C26-B2FE-493C-A5B5-6DCA665DD349Q27024008-CABE5E74-804E-45E0-B1AC-01496B897EACQ27024178-FAFB5497-9C26-4738-A423-AC5F08D8DC54Q27024279-B52A9AA0-85B6-4960-8AB3-2A177956C8A8Q28073079-8A9909C9-0837-4E68-996A-E57F56C425DBQ28571438-0E4BD651-719A-4294-AC7B-74B9D8A7D912Q30394959-499D4DF8-0B29-4FB9-B61C-451F9A4C516AQ30442221-CB7B025B-767E-4C66-8493-44603F42320EQ30530714-A3836D44-A9AC-4A0C-B5F2-696B0C08498AQ30661992-B801CD75-5C5C-49CF-9002-4FB34EE7BCB2Q31071475-9488C396-CB19-4F14-B65C-110CAE04C348Q33565707-E598FA38-27CC-4B4A-8C6E-ED9F3E758275Q33617800-F98FF0FD-AC9D-483D-B20C-9905FD4ED12FQ33639223-BAC2D922-89B7-4338-95DD-B84142EBECF9Q33640339-AC271C26-196C-44C6-852A-7509AF4897B4Q33651931-2A895D79-6001-4665-9C81-270178FD64FAQ33799358-63C452F2-F32F-4748-9D59-04A6651E1E25Q33961078-9049B0DE-132F-4448-BD3C-13D19DEF88ABQ34178646-A664FD0B-281A-4CF6-9660-8C1C7439349DQ34294941-B2DB4A10-0138-48BD-A450-0A5A6F5D3486Q34413027-E9543725-785D-4BB3-A352-A4349EAF360BQ34622653-E8129F7D-1F05-4400-AEEB-F784D0540841Q34623775-7595066E-DDCC-40C8-9C00-D2A6EEB82717Q34777000-81EDEB95-0F49-4348-97F5-67CE1B5D6F94Q35072520-99069769-6999-4ED6-982C-1985296033A5Q35143429-9B256F54-0B1E-42F9-B290-82A2D52E6907Q35196561-CD77A57D-1572-4AF3-A35D-7B5ABA88184DQ35630046-1E1A3707-C0FA-4BC8-BD38-60C6E87B1E38Q35671472-16F2331B-3813-4AE3-925D-66C303F39F35Q35743444-E5C63501-8657-4CAB-AE20-F3B3831B3685Q35900890-0EE42099-D8E6-436F-908A-D12EEE5FAA77Q35939295-3F52E1AF-A768-47CB-A72C-4D2ADDABB3F7Q35976452-322D422E-5200-4E61-BA0E-24976F1FD7E9Q36027150-D575A77B-E0E5-4113-969D-7A5240402BF2Q36107295-13E65F2D-8DFF-48F2-97B3-84C85AEF43E0Q36110797-D960C9F7-1BB1-49F3-B25E-82D5A466D760Q36167458-7B3406B8-D5AC-4812-9B5A-1A894BE7F7F6Q36296735-37167B4F-E51A-419C-B0D3-017992CD70DCQ36421971-24C56398-4974-4075-8468-42FEB6A43273
P2860
Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Cardiac structure and ventricu ...... from Olmsted County, Minnesota
@ast
Cardiac structure and ventricu ...... from Olmsted County, Minnesota
@en
type
label
Cardiac structure and ventricu ...... from Olmsted County, Minnesota
@ast
Cardiac structure and ventricu ...... from Olmsted County, Minnesota
@en
prefLabel
Cardiac structure and ventricu ...... from Olmsted County, Minnesota
@ast
Cardiac structure and ventricu ...... from Olmsted County, Minnesota
@en
P2093
P2860
P1433
P1476
Cardiac structure and ventricu ...... from Olmsted County, Minnesota
@en
P2093
Barry A Borlaug
Carolyn S P Lam
David A Kass
Francesca Bursi
Margaret M Redfield
Richard J Rodeheffer
Steve R Ommen
Véronique L Roger
P2860
P304
P356
10.1161/CIRCULATIONAHA.106.659763
P407
P577
2007-04-02T00:00:00Z